Skip to content

TO SEE THE COMBINATIONAL EFFECT OF TWO TREATMENT TECHNIQUES ON ACTIVITY OF A CHILD WITH CEREBRAL PALSY

COMBINED EFFECT OF TASK ORIENTED ACTIVITY AND MYOFASCIAL RELEASE ON MOBILITY FUNCTION IN CHILDREN WITH SPASTIC CP ALONG WITH CONVENTIONAL THERAPY A RANDOMIZED CONTROL TRIAL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021536
Enrollment
28
Registered
2019-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G809- Cerebral palsy, unspecified

Interventions

Intervention1: MFR(CALF MUSCLE, HAMSTRING MUSCLE, HIP ADDUCTOR MUSCLE) TASK ORIENTED ACTIVITY WALKING ACTIVITY STANDING BALANCE ACTIVITY CONVENTIONAL PHYSIOTHERAPY TREATMENT: MFR(CALF MUSCLE, HAMSTRI

Sponsors

SRINIVAS COLLEGE OF PHYSIOTHERAPY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) SUBJECTS DIAGNOSED WITH SPASTIC CEREBRAL PALSY (DIPLEGIA AND QUADRIPLEGIA) 2) SUBJECTS OF BOTH GENDERS OF AGE BETWEEN 4 TO 10 YEARS 3) ABILITY TO COMPREHEND WITH IQ MORE THAN 50 (BY PSYCHOLOGIST) 4) ABLE TO FOLLOW COMMANDS AND COOPERATE DURING AN EXAMINATION 5) GMFCS LEVEL (I, II, III) 6) ABILITY TO WALK WITH OR WITHOUT WALKING AIDS OR ORTHOTICS

Exclusion criteria

Exclusion criteria: 1) MENTAL RETARDATION 2) ACTIVE MEDICAL CONDITIONS 3) CONGENITAL HEART DISEASE 4) CHILDREN WITH RECURRENT SEIZURES IN LAST 6 MONTHS 5) FIXED SPINAL DEFORMITIES 6) HEAD INJURIES 7) FRACTURE OR INJURIES TO UPPER EXTREMITY AND LOWER EXTREMITY 8) CHILDREN UNDERGONE PRIOR ORTHOPAEDIC SURGERY 9) CHILDREN RECEIVED BOTULINUM TOXIN INJECTION FOR PAST 6 MONTHS 10) CHILDREN WHO ARE ALREADY UNDER MFR AND TOA

Design outcomes

Primary

MeasureTime frame
GMFM FOR ASSESSEING MOTOR FUNCTION BEFORE INTERVENTION TIME UP AND GO TEST FOR ASSESSING MOBILITY BEFORE INTRVENTION MODIFIED ASHWORTH SCALE FOR ASSESING MUSCLE SPASTICITY BEFORE INTERVENTION MODIFIED TARDIEU SCALE FOR ASSESSING MUSCLE TONE BEFORE INTERVENTIONTimepoint: GMFM FOR ASSESSEING MOTOR FUNCTION, TIME POINTS 5 WEEKS TIME UP AND GO TEST FOR ASSESSING MOBILITY, TIME POINTS 5 WEEKS MODIFIED ASHWORTH SCALE FOR ASSESING MUSCLE SPASTICITY, TIME POINTS 5 WEEKS MODIFIED TARDIEU SCALE FOR ASSESSING MUSCLE TONE, TIME POINTS 5 WEEKS

Secondary

MeasureTime frame
GMFM FOR ASSESSEING MOTOR FUNCTION POST INTERVENTION TIME UP AND GO TEST FOR ASSESSING MOBILITY POST INTRVENTION MODIFIED ASHWORTH SCALE FOR ASSESING MUSCLE SPASTICITY POST INTERVENTION MODIFIED TARDIEU SCALE FOR ASSESSING MUSCLE TONE POST INTERVENTIONTimepoint: GMFM FOR ASSESSEING MOTOR FUNCTION, TIME POINTS 5 WEEKS POST INTERVENTION TIME UP AND GO TEST FOR ASSESSING MOBILITY,TIME POINTS 5 WEEKS POST INTRVENTION MODIFIED ASHWORTH SCALE FOR ASSESING MUSCLE SPASTICITY, TIME POINTS 5 WEEKS POST INTERVENTION MODIFIED TARDIEU SCALE FOR ASSESSING MUSCLE TONE,TIME POINTS 5 WEEKS POST INTERVENTION

Countries

India

Contacts

Public ContactVIVEK VIJAYAN MENON

YENEPOYA COLLEGE OF PHYSIOTHERAPY YENEPOYA DEEMED TO BE UNIVERSITY

menonvivek2015@gmail.com9619318353

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026